Go to the list of all blogs
AI dvisor's Avatar
published in Blogs
Nov 06, 2026
TickeronGET DAILY SIGNALS
Why Is NMI Holdings (NMIH) Stock Down -12.72% Today?

Why Is NMI Holdings (NMIH) Stock Down -12.72% Today?

Key Takeaways

  • Shares of NMIH fell about 12.7% on Thursday, trading near $38.64 after closing at $44.27 in the prior session.
  • The primary catalyst was a third-quarter 2026 earnings and revenue miss versus Wall Street consensus estimates.
  • A sharp rise in insurance claims and claim expenses — which more than doubled sequentially — weighed heavily on underwriting profitability.
  • The deterioration in the loss ratio and combined ratio signaled softer credit performance than the previous quarter.
  • Broader market and mortgage-insurance sector context will remain in focus as investors reassess credit risk in the housing market.
  • Traders are watching the default rate, persistency trends, and fourth-quarter credit performance for signs of further pressure.
  • For deeper analysis, explore Price Targets, Earnings, and Forecast data on additional pages.
  • Discover automated trading strategies currently outperforming by visiting Trending AI Robots.

Opening Summary

NMI Holdings, Inc. (NMIH), the parent of National Mortgage Insurance Corporation ("National MI"), is a leading U.S. private mortgage insurer that protects lenders and investors against default-related losses on low-down-payment residential mortgages. The stock sold off sharply on Thursday, dropping roughly 12.72% to about $38.64, down from a prior-session close of $44.27. The decline came as investors digested third-quarter 2026 results that missed consensus estimates, with higher claims costs and weakening underwriting ratios overshadowing continued growth in the company's insured portfolio.

Third-Quarter Earnings Miss

The selloff was driven primarily by a disappointing quarterly report. NMIH reported adjusted earnings of $1.23 per diluted share for the third quarter of 2026, up 1.7% year over year but below the consensus estimate of roughly $1.31 to $1.32 per share. Total revenue of $187.6 million rose about 5% year over year yet also came in short of analyst expectations near $190.6 million. The headline misses on both the top and bottom lines reset investor expectations and triggered a pronounced negative market reaction.

Rising Claims and Weakening Underwriting Ratios

Beneath the headline numbers, the most concerning development was a surge in claims activity. Insurance claims and claim expenses climbed 56.9% year over year to $29.1 million, more than doubling from $13.1 million in the prior quarter. As a result, the loss ratio deteriorated sharply to 18.7% from 8.3% in the second quarter and 12.3% a year earlier, while the combined ratio climbed to 38.5% from 27.7% sequentially. Although management attributed the increase partly to normal seasonal activity and ongoing portfolio seasoning, the magnitude of the jump — coupled with a rise in loans in default to 8,571 and a default rate of 1.23% — raised questions about near-term credit trends.

Solid Fundamentals Offset by Credit Concerns

The quarter was not without positives. New insurance written reached $13.6 billion, and primary insurance-in-force grew 5.2% year over year to a record $229.7 billion. Net investment income rose 20.3% to $32.2 million, and book value per share excluding unrealized investment gains and losses increased 14% year over year to $38.13. The company also repurchased $27.1 million of stock during the quarter. However, annual persistency declined to 80.8% from 83.9% a year earlier, and adjusted return on equity slipped to 13.9% from 15.9% in the prior quarter — dynamics that weighed on sentiment despite the company's otherwise strong capital position.

Market Context and Trading Activity

The decline reflected an earnings-driven repricing rather than a broad market dislocation. Trading activity was elevated as investors positioned around the results, with the magnitude of the move consistent with a significant earnings surprise. The private mortgage insurance sector is highly sensitive to credit-quality signals, so the deterioration in NMIH's loss and combined ratios attracted outsized scrutiny relative to the company's continued revenue and portfolio growth. Whether the move signals broader pressure across mortgage insurers or a company-specific reset remains a key question for the sector.

What Comes Next for NMIH

Looking ahead, investors will focus on whether the elevated claims activity in the third quarter proves to be a one-quarter seasonal effect or the start of a sustained normalization in credit costs. Key indicators include the trajectory of the default rate, persistency levels, and the loss ratio in upcoming quarters, as well as broader housing-market conditions and mortgage rates. The company's substantial capital cushion and comprehensive reinsurance program provide downside support, but any further deterioration in underwriting profitability could keep pressure on the stock. Risks include shifts in housing policy, changes to GSE requirements, and potential volatility in the insured portfolio's credit performance.

Trending AI Robots

Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots that are performing strongly under current market conditions. Tickeron offers hundreds of automated bots covering thousands of tickers, each varying by strategy, timeframe, performance metrics, and the symbols it trades. Only the strongest performers are featured in this section, giving traders a focused view of strategies currently in favor. Explore the page to see which approaches are leading the market today.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NMIH

NMIH in upward trend: price may jump up because it broke its lower Bollinger Band on November 06, 2026

NMIH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 25 of 34 cases where NMIH's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NMIH's RSI Oscillator exited the oversold zone, 15 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 58%.

The Moving Average Convergence Divergence (MACD) for NMIH just turned positive on October 09, 2026. Looking at past instances where NMIH's MACD turned positive, the stock continued to rise in 22 of 43 cases over the following month. The odds of a continued upward trend are 51%.

The 10-day moving average for NMIH crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.

Following a +2.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where NMIH advanced for three days, in 227 of 333 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

The Aroon Indicator entered an Uptrend today. In 177 of 284 cases where NMIH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 34 of 62 cases where NMIH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 55%.

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NMIH as a result. In 48 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 55%.

NMIH moved below its 50-day moving average on November 06, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NMIH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 31 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. NMIH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.085) is normal, around the industry mean (0.997). P/E Ratio (7.549) is within average values for comparable stocks, (11.415). NMIH's Projected Growth (PEG Ratio) (3.040) is slightly higher than the industry average of (0.944). Dividend Yield (0.000) settles around the average of (0.502) among similar stocks. NMIH's P/S Ratio (4.575) is slightly higher than the industry average of (2.529).

Industry description

Specialty insurance typically caters to niche-markets, and covers items that are special or unique and/or items that are not typically covered under other insurance policies. Restoration or purchase of a one-of-a-kind collector’s item, high-value home, recreational vehicles, sailboat or even jet skis, horses and farms, all-terrain vehicle, funerals, museums and fine art collections are some examples– one or more of which are covered by a specialty insurance provider. In some cases, a specialty insurance could also complement someone’s existing auto, home and umbrella policies. Markel Corp, for Fidelity National Financial, Inc., Assurant, Inc. and Athene Holding Ltd. are examples of specialty insurance providers.

Market Cap

The average market capitalization across the Specialty Insurance Industry is 3.88B. The market cap for tickers in the group ranges from 2.22M to 11.76B. FNF holds the highest valuation in this group at 11.76B. The lowest valued company is MMMM at 2.22M.

High and low price notable news

The average weekly price growth across all stocks in the Specialty Insurance Industry was 0%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was -3%. FNF experienced the highest price growth at 8%, while NMIH experienced the biggest fall at -9%.

Volume

The average weekly volume growth across all stocks in the Specialty Insurance Industry was 22%. For the same stocks of the Industry, the average monthly volume growth was 21% and the average quarterly volume growth was 16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 43
Price Growth Rating: 51
SMR Rating: 83
Profit Risk Rating: 55
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of private mortgage insurance services

Industry SpecialtyInsurance

Industry
Property Or Casualty Insurance
Address
2100 Powell Street
Phone
+1 855 530-6642
Employees
225
Web
https://www.nationalmi.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of $1.54 billion, reflecting approximately 74% year-over-year growth. Consensus earnings per share (EPS) forecast stands at $0.28, up over 115% from the prior year.
Analysts expect Q1 2026 revenue of $3.00 billion, up 8% from $2.77 billion in the year-ago quarter. Consensus earnings per share (EPS) estimate stands at $4.31, reflecting steady profitability from the cystic fibrosis (CF) portfolio.